Advertisement

Topics

TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial Results

06:45 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
– Pipeline of two late-stage product candidates advancing towards commercialization, with launch of TX-004HR expected in fourth quarter 2017 pending regulatory approval – – Management to host conference call today...

Other Sources for this Article

TherapeuticsMD, Inc.
Investor Contact
David DeLucia, 561-961-1900
Director, Investor Relations
David.DeLucia@TherapeuticsMD.com
or
Media Contact
SparkBioComm
Ami Knoefler, 650-739-9952
Ami@SparkBioComm.com

NEXT ARTICLE

More From BioPortfolio on "TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...